Featured Research

from universities, journals, and other organizations

New Insights Into The Burden Of Severe S. Pyogenes Infection Across Europe

Date:
November 26, 2008
Source:
Helsingin yliopisto (University of Helsinki)
Summary:
Researcher have developed new insights into the burden, risk factors and mortality associated with severe S. pyogenes infection in Europe. Diseases caused by the Lancefield group A streptococcus, Streptococcus pyogenes, are amongst the most challenging to clinicians and public health specialists alike. This common bacterium of the throat and skin causes ‘strep throat’, skin infections, scarlet fever, and severe diseases such as pneumonia, septicaemia and necrotising fasciitis.

A collaborative study between the University of Helsinki and the National Public Health Institute (KTL), Finland, and the UK Health Protection Agency has brought some new insights into the burden, risk factors and mortality associated with severe S. pyogenes infection in Europe.

Related Articles


Epidemiological studies can play an important role in identifying factors associated with risk of disease, manifestation of particular syndromes or poor survival. This can be of value in targeting prevention activities, as well directing further basic research, paving the way for the identification of novel therapeutic targets.

Diseases caused by the Lancefield group A streptococcus, Streptococcus pyogenes, are amongst the most challenging to clinicians and public health specialists alike. This common bacterium of the throat and skin causes ‘strep throat’, skin infections, scarlet fever, and severe diseases such as pneumonia, septicaemia and necrotising fasciitis. Although severe infections caused by this organism are relatively uncommon, affecting around 3 per 100,000 of the population per annum in developed countries, the case fatality is high relative to many other infections.

A European network Strep-EURO, launched in September 2002, provided an opportunity to explore epidemiological patterns across Europe. Twelve participants across eleven countries took part in the network, funded by the Fifth Framework Programme of the EU and co-ordinated by the University of Lund in Sweden. This study arose from a new collaboration between the Health Protection Agency, the National Public Health Institute in Helsinki (KTL) and the University of Helsinki, Finland.

Theresa Lamagni, of the HPA provided the epidemiological lead for the Strep-EURO network, which succeeded in collecting a wealth of data on over 5000 cases identified over two years (2003-04). Analysis of these data has yielded important new information on the epidemiology of severe S. pyogenes infections in Europe during the 2000s. Comprehensive epidemiological data on these infections were obtained for the first time from France, Greece and Romania.

Incidence estimates identified a general north-south gradient, from high to low. Remarkably similar rates were observed among the three Nordic participants, between 2.2 and 2.3 per 100,000 population. Rates in the UK were higher still, 2.9/100,000, elevated by an upsurge in disease in injecting drug users. Rates from these northern countries were reasonably close to those observed in the USA and Australia during this period. In contrast, rates of reports in the more central and southern countries (Czech Republic, Romania, Cyprus and Italy) were substantially lower, 0.3 to 1.5 per 100,000 population, a possible reflection of poorer uptake of microbiological diagnostic methods within these countries.

Analysis of project data brought some new insights into risk factors for severe S. pyogenes infection, especially the importance of injecting drug users in the UK, with infections in this group fundamentally reshaping the epidemiology of these infections during this period. Analysis of additional data from the UK found use of NSAIDs (nonsteroidal anti-inflammatory drugs) to be significantly associated with development of streptococcal toxic shock syndrome (STSS), This research is providing us with valuable information surrounding the role of NSAIDs in the development of severe disease.

Several other novel findings arose through this work, including the high degree of congruence in seasonal patterns between countries and the seasonal changes in case fatality rates.

As a largely community-acquired infection, occurring sporadically and diffusely throughout the population, opportunities for control of severe infections caused by S. pyogenes remain limited, primarily involving contact chemoprophylaxis where clusters arise. Analysis of UK Strep-EURO data were used to quantify the risk to household contacts of cases, forming the basis of UK guidance on the management of contacts, the first developed by any country in Europe.

Theresa Lamagni, one of the principal investigators for the project said, “This is one of the most comprehensive studies of severe group A streptococcal infections ever undertaken and has provided vital information on how common these infections are in Europe, who is affected and what factors influence the risk of death.

“The research builds on our previous understanding of severe streptococcal infections and will be invaluable in the development of possible vaccines against these diseases.”


Story Source:

The above story is based on materials provided by Helsingin yliopisto (University of Helsinki). Note: Materials may be edited for content and length.


Cite This Page:

Helsingin yliopisto (University of Helsinki). "New Insights Into The Burden Of Severe S. Pyogenes Infection Across Europe." ScienceDaily. ScienceDaily, 26 November 2008. <www.sciencedaily.com/releases/2008/11/081126075611.htm>.
Helsingin yliopisto (University of Helsinki). (2008, November 26). New Insights Into The Burden Of Severe S. Pyogenes Infection Across Europe. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2008/11/081126075611.htm
Helsingin yliopisto (University of Helsinki). "New Insights Into The Burden Of Severe S. Pyogenes Infection Across Europe." ScienceDaily. www.sciencedaily.com/releases/2008/11/081126075611.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins